Bayer celebrates more than a decade as Top Employer
MISSISSAUGA, ON, November 7, 2017 – For 11 years in a row Bayer has been recognized as a Top 100 Employer in Canada. Bayer’s management team prides itself on creating a strong environment that supports employees in the workplace as well as within their community.
“A big part of what makes Bayer such a great place to work is our people,” said Lynda Newcomb, Vice President, Human Resources. “We are more driven than ever to challenge the status quo and continuously improve the way we engage with each other.”
By focusing on our employees, customers, and the communities we work in, Bayer strives to make a positive difference in the lives of Canadians. Bayer promotes a culture in which employees live the company’s LIFE values of Leadership, Integrity, Flexibility and Efficiency.
“We work hard to provide a work place that encourages employees to collaborate with each other to foster strong teamwork, innovative thinking, resiliency and community engagement,” Newcomb said.
Bayer in Canada has over 1,500 employees across the country focused on three business divisions: Pharmaceutical (prescription drugs), Consumer Health (selfcare medications) and Crop Science (agriculture crop solutions). Company offices and facilities are located across the country with the head office located in Mississauga, Ontario. In 2013, the company celebrated its 150th anniversary and stands by its principals of sustainable development, and its social and ethical responsibilities as a corporate citizen.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. For more information, go to www.bayer.com.
For information on Bayer in Canada, go to www.bayer.ca
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.